Gene therapy for HIV infections: Intracellular immunization.

The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses
A Piché

Abstract

Despite significant advances in the treatment of human immunodeficiency virus (HIV) infection in the past 10 years, it remains an incurable disease. The inability of traditional drug-based therapies to inhibit HIV replication effectively for extended periods of time has stimulated intense research to develop novel approaches for this disease. Current understanding of HIV molecular biology and pathogenesis has opened the way for the development of gene therapy strategies for HIV infections. In this context, a number of intracellular immunization-based strategies have been evaluated, and some of them have reached the stage of phase I/II human clinical trials. These strategies include the use of single-chain antibodies, capsid-targeted viral inactivation, transdominant negative mutants, ribozymes, antisense oligonucleotides and RNA decoys. While a number of issues remain to be studied before intracellular immunization can be applied to the treatment of HIV infections, the significant progress already made in this field is likely to lead to clinical applications.

Citations

Dec 26, 2013·Viruses·Anjie Zhen, Scott Kitchen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Related Papers

Expert Opinion on Biological Therapy
Ananthalakshmi PoluriRichard E Sutton
Clinical Microbiology Reviews
B A Bunnell, R A Morgan
Clinical and Experimental Immunology
R A Morgan
© 2022 Meta ULC. All rights reserved